Robert Hershberg
Directeur/Bestuurslid bij Eleusis Holdings Ltd.
Profiel
Robert Hershberg is associated with two firms, Eleusis Holdings Ltd.
and Frazier Management LLC.
He holds the title of Director at Eleusis Holdings Ltd.
and is a Venture Partner at Frazier Management LLC since 2020.
Actieve functies van Robert Hershberg
| Bedrijven | Functie | Begin |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01-01-2020 |
Eleusis Holdings Ltd.
 Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Eleusis Holdings Ltd.
Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Commercial Services |
